<DOC>
	<DOCNO>NCT02126956</DOCNO>
	<brief_summary>The study conduct investigate metabolism mass balance ACT-128800 , identify elimination pathway ( metabolism excretion ) ACT-128800 compare know metabolic profile ACT-128800 animal .</brief_summary>
	<brief_title>Mass Balance , Pharmacokinetics , Metabolism 14C-labeled ACT-128800 Administered Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Signed informed consent prior studymandated procedure . Male age 45 65 year ( inclusive ) screening . No clinically significant finding physical examination perform screen . Body mass index ( BMI ) 1828 kg/m^2 ( inclusive ) screening . Systolic blood pressure 100145 mmHg , diastolic blood pressure 5090 mmHg , heart rate 5590 bpm ( inclusive ) , measure leading arm , 5 minute supine position screening . These criterion also meet administration first dose . 12lead electrocardiogram without clinically relevant abnormality screen . Clinical chemistry , hematology , urinalysis result deviate normal range clinically relevant extent screening . Negative result urine drug screen screen . Ability communicate well investigator local language , understand comply requirement study . Known hypersensitivity excipients drug formulation . Treatment another investigational drug within 3 month prior screen . History clinical evidence alcoholism drug abuse within 3year period prior screen . Excessive caffeine consumption , define ≥ 800 mg per day screening . History clinical evidence disease and/or existence surgical medical condition , might interfere absorption , distribution , metabolism excretion study drug . Smoking within 3 month prior screen . Any immunosuppressive treatment within 6 week study drug administration . Previous treatment prescribe overthecounter medication ( include herbal medicine St John 's Wort ) within 2 week prior screen . Loss 250 mL blood within 3 month prior screen . Lymphopenia ( &lt; 1,100 lymphocytes/μL ) . Viral , fungal , bacterial protozoal infection within 4 week study drug administration . Positive hepatitis B hepatitis C serology , except vaccinated subject , screen . Positive human immunodeficiency virus serology screen . Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol . Legal incapacity limit legal capacity screening . Exposure artificial ionizing radiation ( e.g. , Xray , thyroid scan , study radiolabeled compound ) 12month period screening . A history clinically relevant constipation ( define last 3 day ) 4week period screening .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>ACT-128800</keyword>
</DOC>